The head of AstraZeneca in the UK says the country's deal on paying pharma for medicines is not delivering on its promises, and warned her firm would not sign up to the deal again.
The latest Pharmaceutical Price Regulation Scheme (PPRS) is barely into its second year of operation but with rising payments to the Department of Health (DH) confirmed at the end of the first
